Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moots

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|April 1, 1992
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytesJ Morrison, J Elvin, F Latron, et al.
Immunogenetics|January 1, 1991
Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutantsG Lombardi, M Matsui, R Moots, et al.
Science (New York, N.Y.)|August 14, 1992
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cellsF Latron, L Pazmany, J Morrison, et al.
British Journal of Rheumatology|March 6, 1998
Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)A R Exley, P A Bacon, R A Luqmani, et al.
Gut|November 21, 1998
Intestinal permeability and inflammation in patients on NSAIDsG Sigthorsson, J Tibble, J Hayllar, et al.
Transplantation Proceedings|February 1, 1991
Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residuesG Lombardi, M Matsui, R Moots, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Rheumatology (Oxford, England)|January 20, 2005
Leflunomide in rheumatoid arthritis: recommendations through a process of consensusP Maddison, P Kiely, B Kirkham, et al.
Annals of the Rheumatic Diseases|October 2, 2014
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17S Lightman, S R J Taylor, C Bunce, et al.
Arthritis and Rheumatism|October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinaprilA E Gliddon, C J Doré, C M Black, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|April 1, 1992
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytesJ Morrison, J Elvin, F Latron, et al.
Immunogenetics|January 1, 1991
Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutantsG Lombardi, M Matsui, R Moots, et al.
Science (New York, N.Y.)|August 14, 1992
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cellsF Latron, L Pazmany, J Morrison, et al.
British Journal of Rheumatology|March 6, 1998
Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)A R Exley, P A Bacon, R A Luqmani, et al.
Gut|November 21, 1998
Intestinal permeability and inflammation in patients on NSAIDsG Sigthorsson, J Tibble, J Hayllar, et al.
Transplantation Proceedings|February 1, 1991
Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residuesG Lombardi, M Matsui, R Moots, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Rheumatology (Oxford, England)|January 20, 2005
Leflunomide in rheumatoid arthritis: recommendations through a process of consensusP Maddison, P Kiely, B Kirkham, et al.
Annals of the Rheumatic Diseases|October 2, 2014
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17S Lightman, S R J Taylor, C Bunce, et al.
Arthritis and Rheumatism|October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinaprilA E Gliddon, C J Doré, C M Black, et al.
Pageof 3